Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
www.ahrq.gov

Table 2.1
Percent of surgical discharges with postoperative pneumonia events, catheter-associated urinary tract infection, or venous thromboembolic events, United States, 2005a
Population group 2005
Exposed Adverse events Percent Standard error
Total   9,011 590 6.55 0.26
Age Under 65 1,091 68 6.23 0.73
65-74 2,883 151 5.24 0.41
75-84 3,265 239 7.32 0.46
85 and over 1,772 132 7.45 0.62
Gender Male 3,645 210 5.76 0.39
Female 5,366 380 7.08 0.35
Race White 7,795 349 4.48 0.23
Black 746 56 7.51 0.96
Other 470 185 39.36 2.25
Diabetes Yes 2,833 271 9.57 0.55
No 6,178 319 5.16 0.28
Obesity Yes 1,159 222 19.15 1.16
No 7,852 368 4.69 0.24
Cerebrovascular disease Yes 2,125 262 12.33 0.71
No 6,886 328 4.76 0.26
CHF/pulmonary edema Yes 2,893 326 11.27 0.59
No 6,118 264 4.32 0.26
COPD Yes 2,780 252 9.06 0.54
No 6,231 338 5.42 0.29
Smoking Yes 1,311 197 15.03 0.99
No 7,700 393 5.10 0.25
Corticosteroids Yes 680 211 31.03 1.77
No 8,331 423 5.08 0.24
Coronary artery disease Yes 3,842 318 8.28 0.44
No 5,169 272 5.26 0.31
Renal disease Yes 2,283 301 13.18 0.71
No 6,728 289 4.30 0.25

a Data include Medicare beneficiaries discharged from January to December. Venous thromboembolic events include 30-day postoperative readmissions for pneumonia and venous thromboembolic events.

Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease.

Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.

 
AHRQ Advancing Excellence in Health Care